# Valora Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/valora-therapeutics

- Industry: Biotechnology
- Headquarters: La Jolla, US
- Website: www.valoratherapeutics.com
- Total disclosed funding: $13M
- Latest round: Seed (Jul 9, 2024)
- Investors on record: 5

## About

Based in California, US, and founded in 2023 by Carolyn Bertozzi, Valora Therapeutics Inc., a.k.a. Valora Therapeutics is a biotechnology company that specializes in immunotherapy development. In November 2024, Valora Therapeutics Inc. raised USD 30 million in seed funding co-led by Avalon Bio Ventures, Bregua Corporation, and TigerGene LLC, with participation from Alexandria Venture Investments and Correlation Ventures. As of November 2023, Miguel Garcia-Guzman is the CEO of the company.

Valora Therapeutics specializes in immunotherapy solutions through its proprietary AbLec™ platform, which focuses on decoding the complex sugar code involved in cellular and immune interactions. The platform addresses deficiencies in immune communication prevalent in various diseases, offering a novel approach to treatment. By leveraging advancements in glycobiology, Valora Therapeutics aims to develop therapies that can significantly improve patient outcomes across a broad range of conditions, specifically for patients suffering from immune-related diseases, including cancer and autoimmune disorders.

Valora Therapeutics plans to utilize its proceeds from November 2024 funding to further explore and develop the full potential of the AbLec platform, advancing lead molecules into preclinical development and validating specific mechanisms of action.

## Funding rounds

- Seed, Jul 9, 2024, $13M — Alexandria Venture Investments, Correlation Ventures, Bregua Corporation, Avalon Bio Ventures, TigerGene LLC

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Seed
- Correlation Ventures (https://capitalatlas.ai/funds/correlation-ventures) — Seed
- Bregua Corporation — Seed
- Avalon Bio Ventures (https://capitalatlas.ai/funds/avalon-bio-ventures) — Seed
- TigerGene LLC — Seed